These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24681931)

  • 1. [Clinical aspects of primary myelofibrosis in Japan].
    Shimoda K; Takenaka K; Kitanaka A; Akashi K
    Rinsho Ketsueki; 2014 Mar; 55(3):289-94. PubMed ID: 24681931
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
    Kerbauy DM; Gooley TA; Sale GE; Flowers ME; Doney KC; Georges GE; Greene JE; Linenberger M; Petersdorf E; Sandmaier BM; Scott BL; Sorror M; Stirewalt DL; Stewart FM; Witherspoon RP; Storb R; Appelbaum FR; Deeg HJ
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):355-65. PubMed ID: 17317589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis.
    Gupta V; Kröger N; Aschan J; Xu W; Leber B; Dalley C; Sabloff M; Lipton JH; Messner H; Brune M
    Bone Marrow Transplant; 2009 Sep; 44(5):317-20. PubMed ID: 19234505
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institution.
    Nishihori T; Perkins J; Kim J; Field T; Pidala J; Roman-Diaz J; Komrokji RS; Fernandez HF; Anasetti C; Kharfan-Dabaja MA
    Am J Hematol; 2010 Nov; 85(11):904-7. PubMed ID: 20890908
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis.
    Lissandre S; Bay JO; Cahn JY; Porcher R; Cacheux V; Cabrespine A; Cornillon J; Cassinat B; Peffault de Latour R; Socie G; Robin M
    Bone Marrow Transplant; 2011 Apr; 46(4):557-61. PubMed ID: 21042309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelofibrosis: biology and treatment options.
    Cervantes F
    Eur J Haematol Suppl; 2007 Oct; (68):13-7. PubMed ID: 17727559
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of anabolic steroids on anemia in myelofibrosis with myeloid metaplasia: retrospective analysis of 39 patients in Japan.
    Shimoda K; Shide K; Kamezaki K; Okamura T; Harada N; Kinukawa N; Ohyashiki K; Niho Y; Mizoguchi H; Omine M; Ozawa K; Haradaa M
    Int J Hematol; 2007 May; 85(4):338-43. PubMed ID: 17483079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary chronic myelofibrosis in the Japanese population].
    Okamura T; Shimoda K
    Rinsho Ketsueki; 2005 May; 46(5):330-8. PubMed ID: 16444966
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan.
    Takenaka K; Shimoda K; Uchida N; Shimomura T; Nagafuji K; Kondo T; Shibayama H; Mori T; Usuki K; Azuma T; Tsutsumi Y; Tanaka J; Dairaku H; Matsuo K; Ozawa K; Kurokawa M; Arai S; Akashi K
    Int J Hematol; 2017 Jan; 105(1):59-69. PubMed ID: 27761702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.
    Nivison-Smith I; Dodds AJ; Butler J; Bradstock KF; Ma DD; Simpson JM; Szer J
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):302-8. PubMed ID: 21620988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.
    Kekre N; Ho VT
    Am J Hematol; 2016 Jan; 91(1):123-30. PubMed ID: 26453238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.
    Schmohl JU; Groh C; Faul C; Vogel W; Möhle R; Wirths S; Schneidawind D; Kanz L; Bethge WA
    Ann Hematol; 2016 May; 95(6):973-83. PubMed ID: 27021303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem-cell transplantation for myelofibrosis.
    Deeg HJ; Appelbaum FR
    N Engl J Med; 2001 Mar; 344(10):775-6. PubMed ID: 11236794
    [No Abstract]   [Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelofibrosis with myeloid metaplasia.
    Tefferi A
    N Engl J Med; 2000 Apr; 342(17):1255-65. PubMed ID: 10781623
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation for myelofibrosis: where are we now?
    Fleischman AG; Maziarz RT
    Curr Opin Hematol; 2013 Mar; 20(2):130-6. PubMed ID: 23314844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janus Kinase Inhibitors and Stem Cell Transplantation in Myelofibrosis.
    El Fakih R; Popat U
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S34-42. PubMed ID: 26297276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis.
    Claudiani S; Marktel S; Piemontese S; Assanelli A; Lupo-Stanghellini MT; Carrabba M; Guggiari E; Giglio F; De Freitas T; Marcatti M; Bernardi M; Corti C; Peccatori J; Lunghi F; Ciceri F
    Hematol Oncol; 2016 Sep; 34(3):154-60. PubMed ID: 25469485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogenic hematopoietic stem cell as curative treatment in myelofibrosis.
    Wardhana ; Datau EA; Rotty LW; Haroen H
    Acta Med Indones; 2011 Oct; 43(4):252-9. PubMed ID: 22156358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.